We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.44B
AUM Growth
+$720M
Cap. Flow
+$270M
Cap. Flow %
4.96%
Top 10 Hldgs %
32.29%
Holding
1,278
New
251
Increased
791
Reduced
201
Closed
31

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$17.4M
2
CAT icon
Caterpillar
CAT
+$11.3M
3
PNC icon
PNC Financial Services
PNC
+$10.7M
4
BAC icon
Bank of America
BAC
+$9.3M
5
DE icon
Deere & Co
DE
+$8.44M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$28.7M
2
MRK icon
Merck
MRK
+$24.3M
3
PG icon
Procter & Gamble
PG
+$15.6M
4
CRM icon
Salesforce
CRM
+$11.5M
5
GE icon
GE Aerospace
GE
+$9.87M

Sector Composition

Rank Sector Weight
1 Technology 29.93%
2 Consumer Discretionary 14.45%
3 Financials 11.41%
4 Healthcare 11.4%
5 Communication Services 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDEX
1226
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$64K ﹤0.01%
+179
New +$63.9K
DFTX
1227
Definium Therapeutics
DFTX
$5.89B
$61K ﹤0.01%
+1,175
New +$61.7K
AGEN
1228
Agenus
AGEN
$352M
$59K ﹤0.01%
+550
New +$41.2K
GSAT icon
1229
Globalstar
GSAT
$10.6B
$59K ﹤0.01%
+2,217
New +$43.5K
ENDP
1230
DELISTED
Endo International plc
ENDP
$59K ﹤0.01%
+12,510
New +$71.7K
DHC
1231
Diversified Healthcare Trust
DHC
$1.9B
$53K ﹤0.01%
+12,758
New +$52.7K
CCO icon
1232
Clear Channel Outdoor Holdings
CCO
$1.22B
$52K ﹤0.01%
+19,884
New +$47.7K
IVR icon
1233
Invesco Mortgage Capital
IVR
$799M
$51K ﹤0.01%
+1,311
New +$49.7K
ASXC
1234
DELISTED
Asensus Surgical, Inc.
ASXC
$41K ﹤0.01%
+12,814
New +$32K
VBIV
1235
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$34K ﹤0.01%
+340
New +$33.1K
VTGN icon
1236
VistaGen Therapeutics
VTGN
$11.4M
$33K ﹤0.01%
+349
New +$25.9K
TCRT icon
1237
Alaunos Therapeutics
TCRT
$4.22M
$29K ﹤0.01%
+74
New +$34.5K
UEC icon
1238
Uranium Energy
UEC
$6.74B
$29K ﹤0.01%
+11,055
New +$33.3K
TOON icon
1239
Kartoon Studios
TOON
$39.9M
$28K ﹤0.01%
+1,546
New +$27K
EMWP
1240
DELISTED
Eros Media World PLC
EMWP
$27K ﹤0.01%
+874
New +$23.9K
GERN icon
1241
Geron
GERN
$983M
$23K ﹤0.01%
+16,429
New +$23.9K
TXMD icon
1242
TherapeuticsMD
TXMD
$25.7M
$23K ﹤0.01%
+380
New +$23K
TNXP icon
1243
Tonix Pharmaceuticals
TNXP
$233M
0
DRRX
1244
DELISTED
DURECT Corp
DRRX
$18K ﹤0.01%
+1,083
New +$18.9K
AMPE
1245
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$17K ﹤0.01%
+35
New +$18.8K
IBIO icon
1246
iBio
IBIO
$69.5M
$15K ﹤0.01%
+20
New +$14.6K
NMTR
1247
DELISTED
9 Meters Biopharma
NMTR
$13K ﹤0.01%
+582
New +$14.3K
ACAD icon
1248
Acadia Pharmaceuticals
ACAD
$5.12B
-11,827
Closed -$305K
AVNS
1249
DELISTED
Avanos Medical
AVNS
-5,307
Closed -$232K
BBWI icon
1250
Bath & Body Works
BBWI
$3.76B
-12,271
Closed -$614K

Similar funds

Xponance's Q2 2021 Portfolio in Review

As of Q2 2021, Xponance held 1,278 positions worth $5.44B, up 15% from $4.72B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Xponance deployed $270M of net new capital in Q2 2021, opening 251 new positions and adding to 791 existing holdings. Its largest new stake was Blackstone: 79,520 shares worth $7.72M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $28.7M trimmed.

  • Xponance's largest Q2 2021 buy was Blackstone: 79,520 shares worth $7.72M.
  • Xponance added most to Home Depot in Q2 2021, an estimated $17.4M increase.
  • Xponance's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $28.7M.
  • Xponance fully exited GE Aerospace in Q2 2021, selling an estimated $9.87M.
  • Xponance's ten largest holdings make up 32% of its $5.44B portfolio in Q2 2021.
  • Xponance opened 251 new positions and closed 31 in Q2 2021.
  • Xponance's portfolio value rose 15% quarter-over-quarter to $5.44B.

Based on Xponance's 13F filing for Q2 2021, filed 12 Aug 2021.